Medical device manufacturers located outside the United Kingdom must understand the regulatory obligations that apply before placing their products on the Great Britain market. One important requirement for many overseas manufacturers is appointing a UK Responsible Person (UKRP).
A UK Responsible Person acts as a designated point of contact between an overseas manufacturer and the UK’s medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). The UKRP has specific regulatory responsibilities and helps ensure that the manufacturer meets applicable requirements.
This guide explains when a UKRP is needed, what the role involves, and how manufacturers can prepare for compliance.
1. What Is a UK Responsible Person?
A UK Responsible Person is an individual or organization established in the United Kingdom and appointed by a manufacturer located outside the UK to perform specified regulatory tasks.
For medical devices placed on the Great Britain market, the UKRP represents the manufacturer in dealings with the MHRA within the scope of the applicable regulations and the written mandate.
The role is particularly relevant to manufacturers based outside the UK that intend to supply medical devices in England, Scotland, or Wales. Northern Ireland operates under a different regulatory framework, so manufacturers must assess its requirements separately.
Appointing a UKRP does not transfer all legal responsibility from the manufacturer. The manufacturer remains responsible for the safety, performance, and regulatory compliance of its devices.
2. Who Needs a UKRP for Medical Devices?
A UKRP for medical devices is generally required when a medical device manufacturer is established outside the UK and intends to place devices on the Great Britain market under the applicable rules.
This can affect manufacturers based in countries such as the United States, India, Canada, Australia, and other markets.
Before appointing a UKRP, manufacturers should confirm:
- Where the manufacturer is legally established.
- Whether the device will be placed on the Great Britain or Northern Ireland market.
- Which UK regulatory requirements apply to the device.
- Whether an existing representative arrangement meets current requirements.
- Whether the proposed UKRP can fulfill the required regulatory duties.
The appointment should be formalized through a written mandate that clearly defines the representative’s responsibilities.
3. UK Responsible Person Requirements
The UK Responsible Person requirements include specific obligations relating to the manufacturer’s regulatory documentation, device registration, and communication with the MHRA.
The UKRP must be established in the UK and formally appointed by the overseas manufacturer. The representative must understand the applicable medical device regulations and be able to carry out the duties assigned under the mandate.
Manufacturers should ensure that the mandate clearly identifies the devices covered, the scope of the appointment, and the responsibilities of each party.
They should also establish processes for sharing updated technical documentation, responding to regulatory requests, and communicating safety-related information.
A UKRP appointment should not be treated as a simple administrative formality. An unclear mandate or an inexperienced representative can create avoidable compliance risks.
4. MHRA Device Registration
MHRA device registration is a key part of the regulatory process for applicable medical devices placed on the Great Britain market.
Before a device is placed on that market, the manufacturer must meet the relevant registration requirements. Where an overseas manufacturer appoints a UKRP, the UKRP generally undertakes the applicable registration steps on the manufacturer’s behalf, in accordance with current MHRA procedures.
The information required depends on the device and the applicable registration rules. Manufacturers should prepare accurate information about the manufacturer, device, classification, and relevant conformity documentation.
It is important to distinguish device registration from conformity assessment or product approval. Registration alone does not establish that a device meets all applicable legal requirements or that it can be marketed without the necessary conformity documentation.
Because regulatory procedures can change, manufacturers should verify the current MHRA guidance before submitting registration information.
5. UKRP Responsibilities
The UKRP responsibilities extend beyond submitting registration details. Under the applicable framework and written mandate, the UKRP may need to:
- Verify that the manufacturer has drawn up the Declaration of Conformity, prepared the applicable technical documentation, and carried out the relevant conformity assessment procedures.
- Maintain access to relevant documentation or ensure it can be made available to the MHRA as required.
- Cooperate with the MHRA on requests for information and regulatory inquiries.
- Forward relevant requests, complaints, or communications to the manufacturer.
- Support regulatory action involving non-compliant devices, including cooperation with corrective measures where required.
- Assist with communication and coordination relating to safety concerns and incidents.
The exact duties depend on the applicable legal provisions and the scope of the mandate. Manufacturers should document how the UKRP and internal regulatory teams will manage requests, complaints, corrective actions, and regulatory deadlines.
6. What Non-UK Manufacturer Medical Devices Need to Prepare
For non-UK manufacturer medical devices, appointing a UKRP is only one part of market-entry planning.
Manufacturers should review the device’s classification, conformity assessment route, labeling, technical documentation, and post-market obligations. They should also determine whether UKCA marking, CE marking under applicable transitional arrangements, or another conformity route is relevant to the device and market.
A practical preparation checklist includes:
- Confirm the intended market and applicable regulatory framework.
- Identify the correct device classification and conformity requirements.
- Appoint a suitable UKRP where required.
- Prepare the written mandate and required device information.
- Complete applicable MHRA registration steps.
- Establish procedures for complaints, incidents, and corrective actions.
- Maintain current technical and regulatory documentation.
Completing these steps before launch can reduce the risk of registration delays and regulatory gaps.
7. UK MDR 2002 Compliance
The UK MDR 2002 compliance framework refers to the UK Medical Devices Regulations 2002, as amended. These regulations provide the principal regulatory framework for medical devices in Great Britain, alongside applicable changes and guidance.
Compliance involves more than appointing a representative. Manufacturers must meet the requirements relevant to their device, including conformity assessment, labeling, documentation, registration, and post-market responsibilities where applicable.
The regulatory position may also depend on the device type, the route used to demonstrate conformity, and current transitional provisions for CE-marked devices.
Manufacturers should review current MHRA guidance and obtain appropriate regulatory advice when the correct route is unclear. Requirements for Northern Ireland should be assessed separately because they differ from those applicable in Great Britain.
Conclusion
A UK Responsible Person is an important regulatory contact for many manufacturers established outside the UK that want to place medical devices on the Great Britain market.
Choosing a qualified representative, defining the mandate, completing applicable MHRA registration, and maintaining the required documentation can help manufacturers manage their regulatory obligations more effectively.
For assistance with UK medical device regulatory planning and market access, visit Cliniexperts International.
